Vitanova Biomedical

01/09/2026

I am excited to share the power of our Light Activated Intracellular Acidosis therapy to treat an aggressive plasma cell tumor in a cat.
www.vitanovabiomedical.com

11/27/2025

I’m thrilled to officially introduce Vitanova Biomedical and share our mission: transforming cancer care with next-generation light-activated therapies.
Our team is pioneering LUXVIVO, a novel cancer treatment proven to kill tumors while minimizing side effects. By leveraging light-activated intracellular mechanisms, we aim to provide safer, more effective options for both companion animals and, ultimately, human patients.
At Vitanova, our approach is scientifically rigorous and innovation-driven. We are currently advancing our pathway to gain FDA approval to treat melanoma in dogs, and are committed to building a foundation for a new era of precision oncology for all companion animals and humans.
This is just the beginning – stay tuned for updates on our journey, breakthroughs in therapy, and opportunities to collaborate. To learn more about us, please visit

Improving the lives of patients and companion animals with cancer and the professionals who care for them.

11/12/2025

We are excited to announce that we have been granted Minor Use/Major Species, or "MUMS" designation by the FDA Centers for Veterinary Medicine for developing our Light Activated Intracellular Acidosis therapy to treat hemangiosarcoma and osteosarcoma in dogs. To learn more, please visit www.vitanovabiomedical.com.

06/28/2019

Vitanova Biomedical was recently interviewed by RedCrow, a crowdfunding company focused on healthcare and social impact startups.

Meet Vitanova Biomedical, an exciting early-stage biotechnology company focusing on transforming cancer therapy. For most cancers, treatment comes with high costs, high risk, and potentially devastating side effects. “There are clear unmet needs surrounding cancer treatment,” explains Vitanova ...

05/19/2019

In preparation for a future fundraising campaign, Vitanova Biomedical is currently soliciting feedback on our funding materials which can be viewed on RedCrow.com. RedCrow is an equity crowdfunding site focused on healthcare and social impact startups. If interested, I would greatly appreciate your feedback on our materials. Please click the attached link! Thank you in advance.

An energy-based cancer therapeutic platform technology involving the photo-activation of a targeted nanoparticle which induces rapid cancer cell death.

05/19/2019

Animated Video of Vitanova Biomedical's Light Activated Intracellular Acidosis (LAIA) Cancer Killing Technology

05/19/2019

InnoSTARS Biopharma & Medical Device, Digital Health and Diagnostics Winners!

05/19/2019

Vitanova Biomedical, Inc. (VNB) in pleased to announce the company was awarded the top prize in the category of Biopharma, Medical Device, Digital Health and Diagnostics at the U.S. China Innovation Alliance's InnoSTARS Competition in Houston, TX! As the winners, VNB will be traveling to China in Q3, 2019 to meet with potential investors, strategic partners and to compete in the industry final.